High-dose-rate intraoperative radiation therapy: The nuts and bolts of starting a program

Shalini Moningi; Elwood P. Armour; Stephanie A. Terezakis; Jonathan E. Efron; Susan L. Gearhart; Trinity J. Bivalacqua; Rachit Kumar; Yi Le; Sook Kien Ng; Christopher L. Wolfgang; Richard C. Zellars; Susannah G. Ellsworth; Nita Ahuja; Joseph M. Herman

doi:10.5114/jcb.2014.42027

High-dose-rate intraoperative radiation therapy: The nuts and bolts of starting a program

Shalini Moningi
, Elwood P. Armour
, Stephanie A. Terezakis
, Jonathan E. Efron
, Susan L. Gearhart
, Trinity J. Bivalacqua
, Rachit Kumar
, Yi Le
, Sook Kien Ng
, Christopher L. Wolfgang
, Richard C. Zellars
, Susannah G. Ellsworth
, Nita Ahuja
, Joseph M. Herman

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

High-dose-rate intraoperative radiation therapy (HDR-IORT) has historically provided effective local control (LC) for patients with unresectable and recurrent tumors. However, IORT is limited to only a few specialized institutions and it can be difficult to initiate an HDR-IORT program. Herein, we provide a brief overview on how to initiate and implement an HDR-IORT program for a selected group of patients with gastrointestinal and pelvic solid tumors using a multidisciplinary approach. Proper administration of HDR-IORT requires institutional support and a joint effort among physics staff, oncologists, surgeons, anesthesiologists, and nurses. In order to determine the true efficacy of IORT for various malignancies, collaboration among institutions with established IORT programs is needed.

Original language	English (US)
Pages (from-to)	99-105
Number of pages	7
Journal	Journal of Contemporary Brachytherapy
Volume	6
Issue number	1
DOIs	https://doi.org/10.5114/jcb.2014.42027
State	Published - 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

High-dose-rate brachytherapy
Intraoperative radiation therapy
Recurrent tumors
Sarcoma

Publisher link

10.5114/jcb.2014.42027

Find It

Find It at U of M Libraries

Cite this

Moningi, S., Armour, E. P., Terezakis, S. A., Efron, J. E., Gearhart, S. L., Bivalacqua, T. J., Kumar, R., Le, Y., Ng, S. K., Wolfgang, C. L., Zellars, R. C., Ellsworth, S. G., Ahuja, N., & Herman, J. M. (2014). High-dose-rate intraoperative radiation therapy: The nuts and bolts of starting a program. Journal of Contemporary Brachytherapy, 6(1), 99-105. https://doi.org/10.5114/jcb.2014.42027

Moningi, S, Armour, EP, Terezakis, SA, Efron, JE, Gearhart, SL, Bivalacqua, TJ, Kumar, R, Le, Y, Ng, SK, Wolfgang, CL, Zellars, RC, Ellsworth, SG, Ahuja, N & Herman, JM 2014, 'High-dose-rate intraoperative radiation therapy: The nuts and bolts of starting a program', Journal of Contemporary Brachytherapy, vol. 6, no. 1, pp. 99-105. https://doi.org/10.5114/jcb.2014.42027

@article{816144fa3eb249e983d8bb11639a4093,

title = "High-dose-rate intraoperative radiation therapy: The nuts and bolts of starting a program",

abstract = "High-dose-rate intraoperative radiation therapy (HDR-IORT) has historically provided effective local control (LC) for patients with unresectable and recurrent tumors. However, IORT is limited to only a few specialized institutions and it can be difficult to initiate an HDR-IORT program. Herein, we provide a brief overview on how to initiate and implement an HDR-IORT program for a selected group of patients with gastrointestinal and pelvic solid tumors using a multidisciplinary approach. Proper administration of HDR-IORT requires institutional support and a joint effort among physics staff, oncologists, surgeons, anesthesiologists, and nurses. In order to determine the true efficacy of IORT for various malignancies, collaboration among institutions with established IORT programs is needed.",

keywords = "High-dose-rate brachytherapy, Intraoperative radiation therapy, Recurrent tumors, Sarcoma",

author = "Shalini Moningi and Armour, \{Elwood P.\} and Terezakis, \{Stephanie A.\} and Efron, \{Jonathan E.\} and Gearhart, \{Susan L.\} and Bivalacqua, \{Trinity J.\} and Rachit Kumar and Yi Le and Ng, \{Sook Kien\} and Wolfgang, \{Christopher L.\} and Zellars, \{Richard C.\} and Ellsworth, \{Susannah G.\} and Nita Ahuja and Herman, \{Joseph M.\}",

year = "2014",

doi = "10.5114/jcb.2014.42027",

language = "English (US)",

volume = "6",

pages = "99--105",

journal = "Journal of Contemporary Brachytherapy",

issn = "1689-832X",

publisher = "Termedia Publishing House Ltd.",

number = "1",

}

TY - JOUR

T1 - High-dose-rate intraoperative radiation therapy

T2 - The nuts and bolts of starting a program

AU - Moningi, Shalini

AU - Armour, Elwood P.

AU - Terezakis, Stephanie A.

AU - Efron, Jonathan E.

AU - Gearhart, Susan L.

AU - Bivalacqua, Trinity J.

AU - Kumar, Rachit

AU - Le, Yi

AU - Ng, Sook Kien

AU - Wolfgang, Christopher L.

AU - Zellars, Richard C.

AU - Ellsworth, Susannah G.

AU - Ahuja, Nita

AU - Herman, Joseph M.

PY - 2014

Y1 - 2014

N2 - High-dose-rate intraoperative radiation therapy (HDR-IORT) has historically provided effective local control (LC) for patients with unresectable and recurrent tumors. However, IORT is limited to only a few specialized institutions and it can be difficult to initiate an HDR-IORT program. Herein, we provide a brief overview on how to initiate and implement an HDR-IORT program for a selected group of patients with gastrointestinal and pelvic solid tumors using a multidisciplinary approach. Proper administration of HDR-IORT requires institutional support and a joint effort among physics staff, oncologists, surgeons, anesthesiologists, and nurses. In order to determine the true efficacy of IORT for various malignancies, collaboration among institutions with established IORT programs is needed.

AB - High-dose-rate intraoperative radiation therapy (HDR-IORT) has historically provided effective local control (LC) for patients with unresectable and recurrent tumors. However, IORT is limited to only a few specialized institutions and it can be difficult to initiate an HDR-IORT program. Herein, we provide a brief overview on how to initiate and implement an HDR-IORT program for a selected group of patients with gastrointestinal and pelvic solid tumors using a multidisciplinary approach. Proper administration of HDR-IORT requires institutional support and a joint effort among physics staff, oncologists, surgeons, anesthesiologists, and nurses. In order to determine the true efficacy of IORT for various malignancies, collaboration among institutions with established IORT programs is needed.

KW - High-dose-rate brachytherapy

KW - Intraoperative radiation therapy

KW - Recurrent tumors

KW - Sarcoma

UR - https://www.scopus.com/pages/publications/84899551989

UR - https://www.scopus.com/pages/publications/84899551989#tab=citedBy

U2 - 10.5114/jcb.2014.42027

DO - 10.5114/jcb.2014.42027

M3 - Review article

AN - SCOPUS:84899551989

SN - 1689-832X

VL - 6

SP - 99

EP - 105

JO - Journal of Contemporary Brachytherapy

JF - Journal of Contemporary Brachytherapy

IS - 1

ER -

High-dose-rate intraoperative radiation therapy: The nuts and bolts of starting a program

Abstract

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this